Literature DB >> 2165120

The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs?

M C Slootweg1, C M Hoogerbrugge, T L de Poorter, S A Duursma, S C van Buul-Offers.   

Abstract

Specific binding to and proliferative actions of insulin-like growth factors-I and -II (IGF-I and -II) on fetal mouse osteoblasts were tested. Membranes of mouse osteoblasts were shown by binding competition studies to possess specific binding sites for IGF-I and IGF-II. When IGF-I was used as a tracer, half-maximal displacement was obtained with 1.11 micrograms IGF-I/l and with 14 micrograms IGF-II/l. Displacement of 125I-labelled IGF-I was accomplished with 2.33 micrograms IGF-II/l and with 55 micrograms IGF-I/l. Affinity cross-linking showed bands of 130 kDa 125I-labelled IGF-I and 260 kDa 125I-labelled IGF-II under reducing conditions, further indicating the presence of classical type-I and -II receptor sites on mouse osteoblasts. Mitogenic effects of IGFs were weak; a combination with epidermal growth factor or fibroblast growth factor showed strong synergistic action however. The possibility of autocrine/paracrine actions of IGFs is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165120     DOI: 10.1677/joe.0.1250271

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.

Authors:  Shoshana Yakar; Ernesto Canalis; Hui Sun; Wilson Mejia; Yuki Kawashima; Philip Nasser; Hayden-William Courtland; Valerie Williams; Mary Bouxsein; Clifford Rosen; Karl J Jepsen
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

Review 2.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

Review 3.  Systems analysis of bone.

Authors:  Karl J Jepsen
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

4.  Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model.

Authors:  John L Fowlkes; Kathryn M Thrailkill; Lichu Liu; Elizabeth C Wahl; Robert C Bunn; Gael E Cockrell; Daniel S Perrien; James Aronson; Charles K Lumpkin
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

5.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Insulinlike growth factor gene expression in human fracture callus.

Authors:  J G Andrew; J Hoyland; A J Freemont; D Marsh
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

Review 7.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

Review 8.  Role of IGF1 and EFN-EPH signaling in skeletal metabolism.

Authors:  Richard C Lindsey; Charles H Rundle; Subburaman Mohan
Journal:  J Mol Endocrinol       Date:  2018-03-26       Impact factor: 5.098

9.  IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand.

Authors:  Lucia Guerra-Menéndez; Maria C Sádaba; Juan E Puche; Jose L Lavandera; Luis F de Castro; Arancha R de Gortázar; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2013-10-25       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.